Founded in 1998, Indegene operates in Enterprise Tech offering digital-first life sciences commercialization services. The company assists biopharmaceutical, emerging biotech, and medical device firms...
Funding stage:
Private Equity
Last funding:
02/02/2021
Total funding:
$220.00 Mn+
Revenue:
Investors
Employee count:
6,800
Last 90d
6,800
Last 90d
Web traffic:
67.95K
67.95K
Last 30d
Last 30d
Glassdoor Rating:
Indegene: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders32
Latest Filing Date12 March 2024- Funding Events75
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Indegene
As of 13 March 2024, Indegene's equity is held by 30 shareholders, with the top three being Nadathur Fareast Pte Ltd, Cadawninvestmentcompany, and Bpc Genesis Fund I Spv Ltd.
Nadathur Fareast Pte Ltd holds the largest stake in Indegene at 23.5% as of 13 March 2024.
As of 13 March 2024, founders collectively hold 29.9% equity in Indegene.
As of 13 March 2024, investors collectively hold 41.4% equity in Indegene.
Indegene's ESOP pool stands at 1.1% of total equity as of 13 March 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links